Valuation: Hikma Pharmaceuticals PLC

Market Cap 4.42B 3.86B 3.56B 3.28B 6.19B 425B 6.33B 42.58B 16.75B 208B 16.59B 16.23B 717B P/E 2026 *
11.3x
P/E 2027 * 10.1x
Enterprise Value 5.89B 5.15B 4.75B 4.38B 8.25B 567B 8.43B 56.76B 22.32B 278B 22.11B 21.63B 956B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.59x
Free-Float
63.65%
Yield 2026 *
4.02%
Yield 2027 * 4.27%
1 day+0.64%
1 week-1.45%
Current month+2.70%
1 month+7.58%
3 months+13.20%
6 months-0.57%
Current year+0.71%
1 week 1,483
Extreme 1483
1,595
1 month 1,469
Extreme 1469
1,762
Current year 1,187
Extreme 1187
1,762
1 year 1,187
Extreme 1187
2,052
3 years 1,187
Extreme 1187
2,360
5 years 1,174.5
Extreme 1174.5
2,703
10 years 814.2
Extreme 814.2
2,768
Manager TitleAgeSince
Chief Executive Officer 69 2025-11-30
Director of Finance/CFO - 2026-02-25
Chief Tech/Sci/R&D Officer 64 2026-02-25
Director TitleAgeSince
Director/Board Member 69 2005-10-13
Director/Board Member 54 2025-12-14
Chairman 69 2014-05-14
Date Insider Type Main position Quantity % Market Cap.
6/1/26 Fiscal year

Executive/Senior Manager

20,982 0.0098%
6/1/26 Fiscal year

Executive/Senior Manager

52,640 0.0245%
6/1/26 Fiscal year

Chief Executive Officer

19,761 0.0092%
Change 5-day change 1-year change 3-year change Capi.($)
+0.64%-1.45%-22.34%-16.95% 4.42B
+0.85%-0.80%+52.79%+161.33% 1,051B
+1.23%-1.53%+54.58%+59.08% 609B
+0.04%+2.58%+34.47%+86.33% 450B
+0.78%-0.71%+29.28%+24.10% 330B
+1.41%+0.58%+35.44%+40.67% 284B
-0.27%-1.87%+22.34%+22.51% 263B
-1.76%+2.37%-20.43%-38.00% 223B
-1.42%+0.80%+24.27%+57.50% 198B
-1.48%+3.43%+24.08%+71.67% 167B
Average +0.00%+0.34%+23.45%+46.82% 357.95B
Weighted average by Cap. +0.37%+0.02%+37.44%+79.51%

Financials

2026 *2027 *
Net sales 3.46B 3.02B 2.79B 2.57B 4.85B 333B 4.95B 33.34B 13.11B 163B 12.99B 12.71B 562B 3.61B 3.16B 2.91B 2.69B 5.06B 348B 5.18B 34.84B 13.7B 170B 13.57B 13.28B 587B
Net income 405M 354M 326M 301M 567M 38.98B 580M 3.9B 1.53B 19.09B 1.52B 1.49B 65.72B 443M 387M 357M 329M 620M 42.62B 634M 4.27B 1.68B 20.87B 1.66B 1.63B 71.86B
Net Debt 1.47B 1.29B 1.19B 1.09B 2.06B 142B 2.11B 14.18B 5.58B 69.37B 5.52B 5.4B 239B 1.31B 1.15B 1.06B 977M 1.84B 127B 1.88B 12.67B 4.98B 62.01B 4.94B 4.83B 213B
Logo Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company engaged in the development, manufacturing and marketing of a broad range of generic, branded and non-licensed pharmaceutical products. Its pharmaceutical operations are conducted through three business segments: Injectables, Branded and Generics. It supplies hospitals across its markets with generic and specialty injectable products, supported by its manufacturing facilities in the United States (US), Europe and Middle East/North Africa (MENA). It supplies branded generic and in-licensed patented products from its local manufacturing facilities to retail and hospital customers across the MENA region. It supplies oral, respiratory and other generic and specialty products to the North American retail market. Its manufacturing facilities in the US supply generic and specialty products to the US and Canada markets across a broad range of therapeutic areas, including respiratory, oncology and pain management.
Employees
9,400
Date Price Change Volume
26-07-17 GBX 1,561.00 +0.64% 1,494,149
26-07-16 GBX 1,551.00 +3.75% 904,819
26-07-15 GBX 1,495.00 -0.07% 752,708
26-07-14 GBX 1,496.00 -4.96% 928,305
26-07-13 GBX 1,574.00 -0.63% 987,734
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
21.00USD
Average target price
24.88USD
Spread / Average Target
+18.45%

Quarterly revenue - Rate of surprise